GCT Participates in the Drug Development and Registration during the Global Pandemic Conference

Today Maria Kokalova, GCT Business Development Associate in Russia, took part in the annual conference “Drug development and registration. Drug research during the COVID-19 pandemic”. 

This event was held virtually and organized in cooperation with a scientific Russian journal “Drug development and registration” («Разработка и регистрация лекарственных средств»). The invited speakers highlighted some of the hottest topics in drug development such as “the research of biotechnological drugs” and “drug research in the context of the COVID-19 pandemic”.

It was a pleasure discussing the recent updates in the Russian pharmaceutical industry with fellow professionals.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.